N.J. is a favorite venue among plaintiffs in nationwide consumer fraud class actions. But most N.J. courts now apply the law of the state where the product was purchased, which may present a barrier to class certification. Also in this issue, we focus on pharma: the First Amendment and pharmaceutical marketing materials, and design defect claims against generic drugs.
Products Liability & Toxic Torts
New Jersey Law Journal
December 14, 2012
This article requires premium access
This article requires premium access to The New Jersey Law Journal. Please sign in or subscribe to read the full text.